Cargando…
A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
OBJECTIVE: Poor sleep is common in inflammatory bowel disease (IBD), associated with worse overall disease course and predominantly attributable to insomnia. While cognitive–behavioural therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia, it is untested in IBD....
Autores principales: | Salwen-Deremer, Jessica K, Smith, Michael T, Aschbrenner, Kelly A, Haskell, Hannah G, Speed, Brittany C, Siegel, Corey A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719151/ https://www.ncbi.nlm.nih.gov/pubmed/34969664 http://dx.doi.org/10.1136/bmjgast-2021-000805 |
Ejemplares similares
-
Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023) -
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022) -
Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease
por: Wang, Ming-Hsi, et al.
Publicado: (2023) -
Effectiveness of disease-specific cognitive–behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD)
por: van den Brink, Gertrude, et al.
Publicado: (2016) -
Changing paradigms in management of inflammatory bowel disease
por: Mao, Ren, et al.
Publicado: (2022)